Back

Therasly

Ghost
mail.gi· irregular· Published 3 months ago

A healthcare consultancy's newsletter offering guides on biopharma strategy, covering real-world evidence after drug approval, biomarker-driven trial design, and clinical development plans for investor readiness. The writing is largely promotional and generic, with limited concrete data or original reporting.

real-world evidencerwebiomarkersclinical development plantarget product profileprecision medicineoncology trialsrare diseasebiotech fundraisingpost-market researchdrug development strategybiopharma consulting
Platform
Ghost
Frequency
Irregular
Latest issue
Jul 14, 2026
Language
English
Written for
Biotech founders, business development teams and life sciences investors
Tone
practical
Tracked since
Oct 22, 2026

Website: https://mail.gi/